Filters

PARK9/ATP13A2 Antibody

PARK9/ATP13A2 Antibody size: 0.1ml 263

Supplier BIOSS PRIMARY UNCONJUGATED ANTIBODIES
Price 263
Size 0.1ml
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long namePARK9/ATP13A2 Primary Polyclonal Antibody
Also known asPARK9/ATP13A2 PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenPARK9/ATP13A2
SpecificityThis is a highly specific antibody against PARK9/ATP13A2
Modification(s)None
Modification site(s)Unmodified antibody
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
Subcellular locationExtracellular
SourceThis antibody was obtained by immunization of the host with KLH conjugated synthetic peptide derived from human ATP13A2
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen ATP13A2 functions to catalyze the conversion of ATP to ADP and a free phosphate, Defects in the gene encoding ATP13A2 are the cause of Kufor-Rakeb syndrome (KRS), Expressed as multiple alternative spliced isoforms, The ATP13A2 gene maps to human chromosome 1, a rare hereditary type of Parkinsonâ, contains over 3, thereby participating in the active transport of ions across cellular membranes, which spans 260 million base pairs, &euro, &trade, 000 genes and comprises nearly 8% of the human genome, 180 amino acid multi-pass membrane protein that belongs to the P5 subfamily of ATPases which play an important role in the transportation of inorganic cations, ATP13A2 is a 1, s disease that exhibits juvenile onset and is characterized by neurodegeneration and dementia
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names ATPase type 13A2, Atp13a2, CLN12, HSA9947, KRPPD, PARK9, Probable cation transporting ATPase 13A2, Probable cation-transporting ATPase 13A2, Putative ATPase, RP1-37C10, 4, AT132_HUMAN
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetPARK9/ATP13A2
Short namePARK9/ATP13A2 Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative namePARK9/ATP13A2 (Antibody to)
Alternative techniqueantibodies
Identity 30213
Gene ATP13A2
Long gene name ATPase 13A2
Synonyms gene PARK9
Synonyms gene name Parkinson disease (autosomal recessive) 9 (Kufor-Rakeb syndrome) ATPase type 13A2
Synonyms HSA9947 CLN12
Locus 1p36, 13
Discovery year 2005-01-12
GenBank acession AL354615
Entrez gene record 23400
Pubmed identfication 15381061 16964263
RefSeq identity NM_022089
Classification Parkinson disease associated genes ATPase orphan transporters
Havana BLAST/BLAT OTTHUMG00000002293
Locus Specific Databases LRG_834

Similar products

Subscribe to our Newsletter